The FDA has granted Breakthrough Therapy designation to GLM101 for phosphomannomutase 2 congenital disorder of glycosylation.

Since 2022, fewer people throughout the US report any alcohol use or heavy alcohol use, suggesting a notable decline in alcohol consumption.

A majority of middle-aged adults in the US report an interest in receiving preventive dementia vaccination if available.

MRI-derived brain age difference predicts dementia progression in memory clinic patients with subjective cognitive decline or MCI.

Kratom use throughout the US appears to be on the rise as addiction centers report seeing an increase in patients seeking treatment.

Exposure to high-level blasts is associated with a higher prevalence of clinical conditions among military service members.

Assessment tools significantly influence the reported global prevalence of cognitive frailty among older adult populations.

Children with multiple co-occurring mental health conditions face a significantly higher risk of experiencing concurrent physical illnesses.

Maintenance doses of mood stabilizers and antipsychotics below specific thresholds increase the risk for hospital readmission in bipolar disorder.

High pulse pressure and low education levels significantly worsen amyloid-related cognitive decline in adults aged 90 years and older.

Treating parental ADHD with stimulant medication alongside behavioral training improves clinical severity for both parent and child.

Paternal postpartum depression in men presents with anger and withdrawal, requiring targeted screening and psychotherapeutic care.